WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a portfolio of potent, novel and differentiated antibiotics designed to be effective against drug resistant bacteria, including multidrug-resistant (MDR) gram negative pathogens, today announced that the Company will present at the 9th annual BIO Investor Forum on Tuesday, October 5, at 9:00 am PT at the Palace Hotel, Pacific Heights room, San Francisco and participate in a panel discussion at Citi's 5th Annual Biotech Day on Tuesday, October 5, from 2:00pm to 3:00 pm ET at the Westin Waterfront Hotel in Boston.
